Literature DB >> 8724255

Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis.

C A Liacouras1, D A Piccoli.   

Abstract

We report the successful treatment of two patients with chronic, intractable Clostridium difficile infection using whole-bowel irrigation with a polyethylene glycol solution (Golytely) as adjunctive therapy. Before this treatment, both patients had recurrent symptoms of diarrhea, weight loss, abdominal pain, and documented C. difficile toxin-positive stools despite multiple pharmacologic treatments. Each child was prescribed myriad drug therapies, including vancomycin, metronidazole, bacitracin, and rifampin. Cholestyramine and lactobacillus were also tried alone and in combination with antibiotics. In each case, symptoms recurred shortly after cessation of therapy. Whole-bowel irrigation was subsequently administered until profuse, clear liquid stools were produced. This treatment was followed by a 3-week course of oral vancomycin and lactobacillus. In both cases, the patient became asymptomatic within 3 days of therapy; they have remained symptom-free for 36 and 48 months, respectively. We suggest that whole-bowel irrigation clears active C. difficile organisms, toxins, and spores from the intestine and is effective as an adjunct to routine therapy for chronic, relapsing C. difficile infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724255     DOI: 10.1097/00004836-199604000-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

1.  New approach to treating Escherichia coli O157:H7?

Authors:  P Beaupré
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

Review 2.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 3.  Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.

Authors:  R Postigo; J H Kim
Journal:  Infection       Date:  2012-07-31       Impact factor: 3.553

4.  Treatment of Recurrent Clostridium difficile Diarrhea.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

Review 5.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

Review 6.  Clostridium difficile-associated disease: changing epidemiology and implications for management.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatment.

Authors:  R C Shoemaker
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

8.  Possible estuary-associated syndrome: symptoms, vision, and treatment.

Authors:  R C Shoemaker; H K Hudnell
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

9.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

10.  An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.

Authors:  Sarah Tomkovich; Ana Taylor; Jacob King; Joanna Colovas; Lucas Bishop; Kathryn McBride; Sonya Royzenblat; Nicholas A Lesniak; Ingrid L Bergin; Patrick D Schloss
Journal:  mSphere       Date:  2021-09-29       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.